ARCHIVES

In Brief: O’Conor Now Top Prospect If Rauscher Leaves; Flood Gives NCI Increase Of Only $11 Million

This article is from The Cancer Letter archive.

Vol. 02 No. 20 | May 14, 1976

Download PDF Visit The Full Archive

Related Articles

The Duke Scandal: NEJM Retracts Potti Paper

March 4, 2011

DCE Concepts Approved

June 27, 1986

NCAB Approved NTP Transfer To NIEHS But Without Much Enthusiasm

May 30, 1980

In Brief: Garb Raps “Hostility Of Executive Branch”; Hew Considers Allowing Grants For Industry

April 25, 1980

Grants Funding: FY(& Year-End Report By NCI On Paylines

October 10, 1997

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005